Study by Artificial Intelligence of the effect of Nutrition and Lifestyle on the composition of the Microbiota and their impact on Inflammatory Bowel Disease
How our project started
Take a moment to read this compelling letter from one of our researchers. Not only is he a seasoned software and Deep Learning engineer, but he's also been navigating life with Ulcerative Colitis for nearly three decades:
"Driven by my passion for intensive sports like running and mountaineering, and my condition as an Ulcerative Colitis patient, I've learned to eat consciously and better. Over the years, I've come to believe that good nutrition and a healthy lifestyle have significantly impacted the long-term progression of my disease. Now, we aim to transform this belief into scientific evidence to benefit others."
"Let food be your medicine and medicine be your food."
Hippocrates, V-IV B.C.
Summary
Our research hypothesis states that by implementing comprehensive dietary and lifestyle interventions, we can positively
modulate the gut microbiota's composition. This could enhance its interaction with the immune system and promote anti-inflammatory responses, offering a potential pathway to better manage Inflammatory Bowel Disease over a patient's lifetime.
Impact of Results
If our hypothesis is confirmed, the benefits of the project would be huge: better control of the disease, reduction in the most expensive components of Ulceratice Colitis (UC) care, increase in the quality of life and reduction in the levels of anxiety and depression, and reduction in the UC long-term complications. Diet and lifestyle intervention would empower patients to cope with their disease by providing them with a tool that they could actively use on a day-to-day basis.
Team
Ascensión Marcos, PhD
Research Professor and Director of the Immunonutrition Group of the Spanish National Research Council (CSIC)
Susana del Pozo, PhD
Associate Professor, Department of Nutrition and Food Science, Complutense University of Madrid. (UCM)
Felipe Lombo, PhD
Professor, Biotechnology in Nutraceuticals and Bioactive Compounds-BIONUC Research Unit, University of Oviedo.
David García, MSc
Software & Machine Learning Engineer, Tech-entrepreneur, and Ulcerative Colitis patient since 1992.
Laura Barrios, PhD
Applied Statistics, Head of the Information Technology Area of the Spanish National Research Council (CSIC).
Sabino Riestra, PhD, MD
Gastroenterology, Head of the IBD Unit at Central University Hospital of Asturias (HUCA).
Pilar Nos, Phd, MD
Head of the Gastrointestinal Department at the Hospital Universitari y Politècnic la Fe, Valencia.
Federico Argüelles, Phd, MD
Professor, Digestive System Department, Hospital Universitario Virgen Marcarena, Seville.
Collaborating entities
Contact
Whether you're an ulcerative colitis patient, a medical professional, an investor, or just someone passionate about our mission, we'd love to hear from you. Specifically, please reach out:
- If you're an ulcerative colitis patient seeking insights from our founder's 30-year journey with the disease.
- For medical professionals interested in collaborations or publications.
- If you're a donor, investor, or potential business partner wanting to expedite our research's impact.
- For companies keen on co-developing dietary and lifestyle interventions.
- IBD community leaders wishing to share our project.
- Media representatives looking for interviews or detailed project insights.
